# Akers Biosciences Inc. (AKER)

Source: https://www.quantisnow.com/company/AKER
Generated: 2026-11-22T11:15:03.675Z

- Ticker: AKER
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IPO year: 2014

## Latest AKER news and filings

- 2021-04-28 21:25 UTC [SEC Form S-3] [SEC Form S-3/A filed by Akers Biosciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-3a-filed-by-akers-biosciences-inc-amendment-668393)
- 2021-04-26 22:05 UTC [SEC Form 3] [SEC Form 3: Williams Caroline C claimed ownership of 5,017,423 units of Common Stock](https://www.quantisnow.com/insight/sec-form-3-williams-caroline-c-claimed-ownership-of-5017423-655272)
- 2021-04-23 01:29 UTC [SEC Form 4] [SEC Form 4 filed by EAGLE CRAIG](https://www.quantisnow.com/insight/sec-form-4-filed-by-eagle-craig-645990)
- 2021-04-23 01:27 UTC [SEC Form 3] [SEC Form 3 filed by EAGLE CRAIG](https://www.quantisnow.com/insight/sec-form-3-filed-by-eagle-craig-645988)
- 2021-04-22 01:56 UTC [SEC Form 8-K] [Akers Biosciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Material Modification to Rights of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/akers-biosciences-inc-filed-sec-form-8-k-completion-of-acquisition-641367)
- 2021-04-22 01:53 UTC [SEC Form 4] [SEC Form 4 filed by Kaplin Adam](https://www.quantisnow.com/insight/sec-form-4-filed-by-kaplin-adam-640963)
- 2021-04-22 01:51 UTC [SEC Form 3] [SEC Form 3 filed by Kaplin Adam](https://www.quantisnow.com/insight/sec-form-3-filed-by-kaplin-adam-640962)
- 2021-04-21 21:55 UTC [SEC Form 4] [SEC Form 4: Schreiber Christopher C exercised 131,750 units of Common Stock at a strike of $0.00 and disposed of $227,798 worth of Common Stock (46,113 units at $4.94), increasing direct ownership by 3,292% to 88,238 units to cover withholding tax](https://www.quantisnow.com/insight/sec-form-4-schreiber-christopher-c-exercised-131750-units-of-640622)
- 2021-04-21 20:55 UTC [SEC Form 4] [SEC Form 4 filed by Uzonwanne Jude](https://www.quantisnow.com/insight/sec-form-4-filed-by-uzonwanne-jude-640338)
- 2021-04-21 20:53 UTC [SEC Form 4] [SEC Form 4: Chapman Christopher C JR was granted 96,475 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-chapman-christopher-c-jr-was-granted-96475-640329)
- 2021-04-21 20:51 UTC [SEC Form 3] [SEC Form 3 filed by Uzonwanne Jude](https://www.quantisnow.com/insight/sec-form-3-filed-by-uzonwanne-jude-640317)
- 2021-04-21 20:49 UTC [SEC Form 3] [SEC Form 3 filed by Chapman Christopher C JR](https://www.quantisnow.com/insight/sec-form-3-filed-by-chapman-christopher-c-jr-640305)
- 2021-04-21 01:44 UTC [SEC Form 4] [SEC Form 4 filed by Rivard Paul](https://www.quantisnow.com/insight/sec-form-4-filed-by-rivard-paul-636567)
- 2021-04-21 01:42 UTC [SEC Form 3] [SEC Form 3 filed by Rivard Paul](https://www.quantisnow.com/insight/sec-form-3-filed-by-rivard-paul-636566)
- 2021-04-21 01:37 UTC [SEC Form 4] [SEC Form 4: SCHROEDER ROBERT C exercised 43,930 units of Common Stock at a strike of $0.00 and disposed of $72,588 worth of Common Stock (14,694 units at $4.94) (withholding obligation)](https://www.quantisnow.com/insight/sec-form-4-schroeder-robert-c-exercised-43930-units-of-636559)
- 2021-04-21 01:35 UTC [SEC Form 4] [SEC Form 4: Silverman Joshua exercised 109,500 units of Common Stock at a strike of $0.00 and disposed of $189,326 worth of Common Stock (38,325 units at $4.94), increasing direct ownership by 2,636% to 71,175 units (withholding obligation)](https://www.quantisnow.com/insight/sec-form-4-silverman-joshua-exercised-109500-units-of-common-636557)
- 2021-04-21 01:32 UTC [SEC Form 4] [SEC Form 4: White Billy Joe exercised 109,500 units of Common Stock at a strike of $0.00 and disposed of $189,326 worth of Common Stock (38,325 units at $4.94), increasing direct ownership by 2,636% to 71,175 units (tax liability)](https://www.quantisnow.com/insight/sec-form-4-white-billy-joe-exercised-109500-units-of-636556)
- 2021-04-16 20:00 UTC [SEC Form 8-K] [Akers Biosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/akers-biosciences-inc-filed-sec-form-8-k-submission-of-matters-625251)
- 2021-04-16 16:30 UTC [Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger](https://www.quantisnow.com/insight/akers-biosciences-and-mymd-pharmaceuticals-announce-stockholder-approval-of-merger-624796)
- 2021-04-13 13:05 UTC [SEC Form 425] [SEC Form 425 filed by Akers Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-akers-biosciences-inc-611933)
- 2021-04-13 13:00 UTC [Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial](https://www.quantisnow.com/insight/akers-proposed-merger-partner-mymd-pharmaceuticals-announces-plans-to-initiate-611567)
- 2021-04-12 13:21 UTC [SEC Form 425] [SEC Form 425 filed by Akers Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-akers-biosciences-inc-607681)
- 2021-04-12 13:00 UTC [Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board](https://www.quantisnow.com/insight/akers-proposed-merger-partner-mymd-pharmaceuticals-announces-formation-of-scientific-607438)
- 2021-03-24 04:15 UTC [SEC Form EFFECT filed by Akers Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-akers-biosciences-inc-546513)
- 2021-03-23 17:44 UTC [SEC Form 424B3 filed by Akers Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-akers-biosciences-inc-544262)
- 2021-03-22 21:21 UTC [SEC Form 425] [SEC Form 425 filed by Akers Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-akers-biosciences-inc-537157)
- 2021-03-22 12:00 UTC [Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals](https://www.quantisnow.com/insight/akers-biosciences-announces-shareholder-meeting-to-vote-on-business-combination-534450)
- 2021-03-19 21:26 UTC [SEC Form 8-K] [SEC Form 8-K filed by Akers Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-akers-biosciences-inc-532591)
- 2021-03-19 18:01 UTC [SEC Form S-4/A filed by Akers Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-akers-biosciences-inc-531590)
- 2021-03-01 22:20 UTC [SEC Form 10-K filed](https://www.quantisnow.com/insight/sec-form-10-k-filed-454717)
- 2021-02-23 14:00 UTC [MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery ](https://www.quantisnow.com/insight/mymd-pharmaceuticals-announces-new-data-on-its-lead-compound-mymd-1-422326)
- 2021-02-22 14:56 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-418176)
- 2021-02-18 19:22 UTC [SEC Schedule 13G] [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-410445)
- 2021-02-18 14:00 UTC [Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission](https://www.quantisnow.com/insight/study-identifies-effects-of-temperature-changes-on-sars-cov-2-transmission-409337)
- 2021-02-18 14:00 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-409311)
- 2021-02-11 22:59 UTC [SEC Form 3] [SEC Form 3 filed by Ian Rhodes](https://www.quantisnow.com/insight/sec-form-3-filed-by-ian-rhodes-386132)
- 2021-02-03 14:30 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-346848)
- 2021-01-29 11:31 UTC [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-328500)
- 2021-01-25 14:27 UTC [SEC Form 8-K/A filed](https://www.quantisnow.com/insight/sec-form-8-ka-filed-310097)
- 2021-01-15 22:24 UTC [SEC Form S-4 filed](https://www.quantisnow.com/insight/sec-form-s-4-filed-289621)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AKER
- Earnings history: https://www.quantisnow.com/earnings/AKER
- Dividend history: https://www.quantisnow.com/dividends/AKER
- Insider transactions: https://www.quantisnow.com/insiders/AKER
- Options chain: https://www.quantisnow.com/options/AKER
- SEC 8-K filings only: https://www.quantisnow.com/company/AKER/8-k
- RSS and alerts for AKER: https://www.quantisnow.com/docs/rss-feeds.md
